This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slipped 0.28% to $7.07 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.19% to 4,391.34 and Dow Jones Industrial Average falling 0.03% to 34,746.25. Ocugen Inc. closed $11.70 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Adverum Biotechnologies Inc. (ADVM) remained unchanged, Ocular Therapeutix Inc. (OCUL) fell 2.69% to $9.75, and Kodiak Sciences Inc. (KOD) fell 0.70% to $103.00. Trading volume (10.2 M) remained 2.2 million below its 50-day average volume of 12.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 8, 2021.
(END) Dow Jones Newswires
October 08, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.